4-(4-bromophenyl)-2,6-diphenylpyrimidine

We are 4-(4-bromophenyl)-2,6-diphenylpyrimidine CAS:58536-46-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(4-bromophenyl)-2,6-diphenylpyrimidine
CAS.NO:58536-46-2
Synonyms:4-(4-bromophenyl)-2,6-diphenylpyrimidine
4-(4-bromophenyl)-2,6-diphenylpyrimidine
4-(4-bromo-phenyl)-2,6-diphenyl-pyrimidine
BAEPM-B
2,4-Diphenyl-6-(4-brom-phenyl)-pyrimidin
Molecular Formula:C22H15BrN2
Molecular Weight:387.27200
 
Physical and Chemical Properties:
Melting point:167ºC
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

4-(4-bromophenyl)-2,6-diphenylpyrimidine


Related News: Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.oct-7-enoic acid CAS:18719-24-9 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.5-Chloro-2-fluoropyridine CAS:1480-65-5 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.(3,5-Diphenylphenyl)boronic acid CAS:128388-54-5 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
N-[(1R)-2-[1,1′-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester View Details
(3S,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-hydroxy-6-methylheptanoic acid View Details
3-chloropropoxymethylbenzene View Details
4-iodo-1-butanol manufacturer tert-Butyl 3-oxoazetidine-1-carboxylate manufacturer 2-Ethylbenzenethiol manufacturer 1-(4-methylphenyl)sulfonyl-1,2,4-triazole manufacturer 2′-bromo-biphenyl-4-carbonitrile manufacturer